| 000 | 01392 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513092601.0 | ||
| 264 | 0 | _c19960819 | |
| 008 | 199608s 0 0 fre d | ||
| 022 | _a0151-9638 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPerrot, J L | |
| 245 | 0 | 0 |
_a[Acquired myelodysplastic syndromes after treatment of melanoma with fotemustine and dacarbazine]. _h[electronic resource] |
| 260 |
_bAnnales de dermatologie et de venereologie _c1995 |
||
| 300 |
_a663-6 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; English Abstract; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aBrain Neoplasms _xsecondary |
| 650 | 0 | 4 |
_aDacarbazine _xadverse effects |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFatal Outcome |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMelanoma _xdrug therapy |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyelodysplastic Syndromes _xchemically induced |
| 650 | 0 | 4 |
_aNitrosourea Compounds _xadverse effects |
| 650 | 0 | 4 |
_aOrganophosphorus Compounds _xadverse effects |
| 650 | 0 | 4 |
_aSkin Neoplasms _xdrug therapy |
| 700 | 1 | _aLanthier, K | |
| 700 | 1 | _aBenoit, F | |
| 700 | 1 | _aGraille, M C | |
| 700 | 1 | _aGuy, C | |
| 700 | 1 | _aBertheas, M F | |
| 700 | 1 | _aCambazard, F | |
| 773 | 0 |
_tAnnales de dermatologie et de venereologie _gvol. 122 _gno. 10 _gp. 663-6 |
|
| 999 |
_c8684876 _d8684876 |
||